| 2143 |
Increased, gene expression of AR
Short Name
Increased, gene expression of AR
|
0 |
Molecular |
May 18, 2023 |
May 18, 2023 |
496: Androgen receptor agonism leading to reproduction dysfunction (in zebrafish)
|
| 2144 |
Impaired insulin signaling
Short Name
Impaired insulin signaling
|
0 |
Cellular |
May 25, 2023 |
May 25, 2023 |
497: ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome
|
| 2145 |
Metabolic syndrome
Short Name
Metabolic syndrome
|
0 |
Population |
May 25, 2023 |
May 25, 2023 |
497: ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome
|
| 2146 |
Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
Short Name
Activation of MEK, ERK1/2
|
1 |
Molecular |
May 25, 2023 |
Jul 28, 2023 |
2 AOPs
|
| 2147 |
Decreased, Viable Offspring
Short Name
Decreased, Viable Offspring
|
2 |
Individual |
Jun 2, 2023 |
Apr 10, 2024 |
2 AOPs
|
| 2148 |
Increased LCN2/iron complex binds to SLC22A17 receptor in neuron
Short Name
Increased LCN2/iron complex
|
0 |
Molecular |
Jun 15, 2023 |
Jun 15, 2023 |
498: Increased LCN2/iron complex leading to neurological disorders
|
| 2149 |
Increased intracelluar Iron accumulation
Short Name
Increased intracelluar Iron
|
0 |
Cellular |
Jun 15, 2023 |
Jun 15, 2023 |
2 AOPs
|
| 2150 |
Neurological disorder
Short Name
Neurological disorder
|
0 |
Individual |
Jun 15, 2023 |
Jun 15, 2023 |
3 AOPs
|
| 2151 |
Disruption, neurotransmitter release
Short Name
Disruption, neurotransmitter release
|
1 |
Molecular |
Jun 27, 2023 |
Jul 21, 2023 |
2 AOPs
|
| 2152 |
Epigenetic modification process
Short Name
Epigenetic modification process
|
0 |
Cellular |
Jul 27, 2023 |
Jul 27, 2023 |
503: Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation
|
| 2153 |
Expression of factors ruling proliferation, modified
Short Name
Expression of factors ruling proliferation, modified
|
0 |
Cellular |
Jul 27, 2023 |
Jul 27, 2023 |
503: Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation
|
| 2154 |
Uterine adenocarcinoma (endometrioid adenocarcinoma Type I)
Short Name
endometrioid adenocarcinoma Type I
|
0 |
Organ |
Jul 27, 2023 |
Jul 27, 2023 |
503: Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation
|
| 2155 |
Inhibition of Sulfotransferase E1 (SULT1E1)
Short Name
SULT1E1 inhibition
|
0 |
Molecular |
Jul 28, 2023 |
Aug 14, 2023 |
504: SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level
|
| 2156 |
Increased morbidity of congenital heart defect
Short Name
Increased morbidity of congenital heart defect
|
0 |
Population |
Jul 31, 2023 |
Jul 31, 2023 |
None
|
| 2157 |
Abnormal Cardiac Structure and Function
Short Name
Abnormal Cardiac Structure and Function
|
0 |
Organ |
Jul 31, 2023 |
Jul 31, 2023 |
None
|
| 2158 |
Influenza A Virus (IAV) binds sialic acid glycan receptor
Short Name
IAV binds receptor
|
1 |
Molecular |
Jul 31, 2023 |
Aug 2, 2023 |
506: Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
|
| 2159 |
Influenza A virus (IAV) cell entry
Short Name
IAV cell entry
|
3 |
Cellular |
Aug 11, 2023 |
Oct 3, 2023 |
506: Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
|
| 2160 |
Angiogenesis disfunction
Short Name
Angiogenesis disfunction
|
0 |
Organ |
Aug 19, 2023 |
Aug 19, 2023 |
None
|
| 2161 |
Increase, Vascular disrupting effects
Short Name
Increase, Vascular disrupting effects
|
0 |
Individual |
Aug 19, 2023 |
Aug 19, 2023 |
5 AOPs
|
| 2162 |
Activation, HIF1α
Short Name
Activation, HIF1α
|
0 |
Cellular |
Aug 20, 2023 |
Aug 20, 2023 |
508: Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway
|
| 2163 |
Activation Sema6A
Short Name
Activation Sema6A
|
0 |
Cellular |
Aug 20, 2023 |
Aug 20, 2023 |
508: Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway
|
| 2164 |
Activation, Dll4-Notch pathway
Short Name
Activation, Dll4-Notch pathway
|
0 |
Cellular |
Aug 20, 2023 |
Aug 20, 2023 |
2 AOPs
|
| 2165 |
Activation of PPAR
Short Name
Activation of PPAR
|
0 |
Cellular |
Aug 20, 2023 |
Aug 20, 2023 |
510: Demethylation of PPAR promotor leading to vascular disrupting effects
|
| 2166 |
Abnormal expression of NO
Short Name
Abnormal expression of NO
|
0 |
Cellular |
Aug 20, 2023 |
Aug 20, 2023 |
510: Demethylation of PPAR promotor leading to vascular disrupting effects
|
| 2167 |
Activation of MMP-2 MMP-9
Short Name
Activation of MMP-2 MMP-9
|
0 |
Cellular |
Aug 20, 2023 |
Aug 20, 2023 |
510: Demethylation of PPAR promotor leading to vascular disrupting effects
|